NEVRO
Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.
NEVRO
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
2006-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.nevro.com
Total Employee:
501+
Status:
Active
Contact:
6504333206
Email Addresses:
[email protected]
Total Funding:
355.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Font Awesome Amazon IPv6
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CRG
CRG investment in Debt Financing - Nevro
Accuitive Medical Ventures
Accuitive Medical Ventures investment in Series C - Nevro
MPM Capital
MPM Capital investment in Series C - Nevro
Novo Ventures
Novo Ventures investment in Series C - Nevro
Bay City Capital
Bay City Capital investment in Series C - Nevro
New Enterprise Associates
New Enterprise Associates investment in Series C - Nevro
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Nevro
Mayo Clinic
Mayo Clinic investment in Series C - Nevro
Covidien Ventures
Covidien Ventures investment in Series C - Nevro
Three Arch Partners
Three Arch Partners investment in Series C - Nevro
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-04 | Nevro appoints Stryker veteran as CFO |
Official Site Inspections
http://www.nevro.com Semrush global rank: 290.68 K Semrush visits lastest month: 223.05 K
Unable to get host informations!!!
